Compass Therapeutics, Inc (CMPX) insider trading
Every open-market stock purchase and sale by Compass Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Neil Lerner (C-suite exec) bought $21.3K in the last 90 days, growing their stake 5%.
Last 12 months: insiders bought $96.8K (4 buys) and sold $0 (0 sales). Last close $0.80 on Oct 22, 2026.
Recent CMPX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Neil Lerner (C-suite exec) | Bought | $18.4K |
| Sep 24, 2026 | Neil Lerner (C-suite exec) | Bought | $2.9K |
| Apr 29, 2026 | Jonathan Anderman (General Counsel) | Bought (not open market) | $47.3K |
| Apr 29, 2026 | Jonathan Anderman (General Counsel) | Bought | $47.3K |
| Apr 29, 2026 | Neil Lerner (C-suite exec) | Bought (not open market) | $28.4K |
| Apr 29, 2026 | Neil Lerner (C-suite exec) | Bought | $28.4K |
| Feb 8, 2026 | Thomas J. Schuetz (CEO) | Sold (not open market) | $239K |
| Jan 9, 2026 | Thomas J. Schuetz (CEO) | Sold (not open market) | $250K |
| Jan 2, 2026 | Thomas J. Schuetz (CEO) | Bought (not open market) | $1.3M |
| Jan 2, 2026 | Jonathan Anderman (General Counsel) | Bought (not open market) | $776K |
| Jan 2, 2026 | Barry Shin (CFO) | Bought (not open market) | $646K |
| Jan 2, 2026 | Neil Lerner (C-suite exec) | Bought (not open market) | $323K |
| Jan 2, 2026 | Ellen Chiniara (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Philip Ferneau (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Carl L Gordon (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Mary Ann Gray (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Arjun Prasad (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Jonathan Anderman (General Counsel) | Bought (not open market) | — |
| Jan 2, 2026 | Thomas J. Schuetz (CEO) | Bought (not open market) | — |
| Jan 2, 2026 | Neil Lerner (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Barry Shin (CFO) | Bought (not open market) | — |
| Jan 2, 2026 | Cynthia Sirard (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Richard S Lindahl (Director) | Bought (not open market) | — |
| Jan 2, 2026 | James P Boylan (Director) | Bought (not open market) | — |
| Nov 16, 2025 | Thomas J. Schuetz (CEO) | Sold (not open market) | $213K |
Who's trading CMPX
- Neil Lerner, C-suite exec: bought $49.6K (3 buys), last Oct 1, 2026
- Jonathan Anderman, General Counsel: bought $47.3K (1 buy), last Apr 29, 2026
- Thomas J. Schuetz, CEO: other filings, last Feb 8, 2026
- Philip Ferneau, Director: other filings, last Jan 2, 2026
- Carl L Gordon, 10% owner: other filings, last Jan 2, 2026
- Mary Ann Gray, Director: other filings, last Jan 2, 2026
- Richard S Lindahl, Director: other filings, last Jan 2, 2026
- Arjun Prasad, C-suite exec: other filings, last Jan 2, 2026
- Cynthia Sirard, C-suite exec: other filings, last Jan 2, 2026
- James P Boylan, Director: other filings, last Jan 2, 2026
- Ellen Chiniara, Director: other filings, last Jan 2, 2026
- Barry Shin, CFO: other filings, last Jan 2, 2026
Get free alerts when an insider at Compass Therapeutics, Inc files a new trade →